SCHEMBL6785509

SCHEMBL6785509

O=C(O)c1ccc(CN2CCC(c3c[nH]c4ccccc34)CC2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.67
HDAC3 O15379 1/20 0.67
HDAC4 P56524 1/20 0.67
HDAC7 Q8WUI4 1/20 0.67
HDAC2 Q92769 1/20 0.67
HDAC10 Q969S8 1/20 0.67
HDAC11 Q96DB2 1/20 0.67
HDAC8 Q9BY41 1/20 0.67
HDAC6 Q9UBN7 1/20 0.67
HDAC9 Q9UKV0 1/20 0.67
HDAC5 Q9UQL6 1/20 0.67
CHRM4 P08173 1/20 0.63
OPRM1 P35372 1/20 0.60
OPRK1 P41145 1/20 0.60
OPRL1 P41146 1/20 0.60
KDM4E B2RXH2 1/20 0.57
BRD4 O60885 1/20 0.57
ALDH1A1 P00352 1/20 0.57
POLB P06746 1/20 0.57
CREBBP Q92793 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6783190 0.88 CHRM4 (0.60) HDAC1HDAC3HDAC4HDAC7HDAC2
SCHEMBL9032088 0.88 OPRM1 (0.75) HDAC1HDAC3HDAC4HDAC7HDAC2
SCHEMBL6779774 0.82 HRH2 (0.59) KDM4EBRD4ALDH1A1POLBCREBBP
SCHEMBL6781691 0.82 KDM4E (0.57) HDAC1HDAC3HDAC4HDAC7HDAC2
SCHEMBL7943390 0.82 OPRM1 (0.66) HDAC1HDAC3HDAC4HDAC7HDAC2
SCHEMBL28800093 0.81 KDM4E (0.69) HDAC1HDAC3HDAC4HDAC7HDAC2
SCHEMBL7092859 0.81 HRH2 (0.61) HDAC1HDAC3HDAC4HDAC7HDAC2
SCHEMBL27707244 0.81 KDM4E (0.64) HDAC1HDAC3HDAC4HDAC7HDAC2
SCHEMBL13949838 0.80 HDAC1 (1.00) HDAC1HDAC3HDAC4HDAC7HDAC2
SCHEMBL5359654 0.79 KMT2A (0.62) HDAC1HDAC3HDAC4HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1191246-C Indolylpiperidine derivatives as antihistamines and antiallergic agents ALMIRALL PRODESFARMA SA (ES) 2005-03-02 CN claimed
EP-1183251-B1 INDOLYLPIPERIDINE DERIVATIVES AS ANTIHISTAMINIC AND ANTIALLERGIC AGENTS ALMIRALL PRODESFARMA SA (ES) 2004-02-11 EP claimed
US-6683096-B2 Indolylpiperidine derivatives as antihistaminic and antiallergic agents ALMIRALL PRODESFARMA, S.A. (ES) 2004-01-27 US claimed
JP-2003501424-A 2003-01-14 JP claimed
US-20020147344-A1 Indolylpiperidine derivatives as antihistaminic and antiallergic agents ALMIRALL PRODESFARMA, S.A. (ES) 2002-10-10 US claimed
EP-1183251-A1 INDOLYLPIPERIDINE DERIVATIVES AS ANTIHISTAMINIC AND ANTIALLERGIC AGENTS Almirall Prodesfarma, S.A. (ES) 2002-03-06 EP claimed
WO-2000075130-A1 INDOLYLPIPERIDINE DERIVATIVES AS ANTIHISTAMINIC AND ANTIALLERGIC AGENTS ALMIRALL PRODESFARMA, S.A. (ES) 2000-12-14 WO claimed
CN-1191246-C Indolylpiperidine derivatives as antihistamines and antiallergic agents ALMIRALL PRODESFARMA SA (ES) 2005-03-02 CN disclosed
EP-1183251-B1 INDOLYLPIPERIDINE DERIVATIVES AS ANTIHISTAMINIC AND ANTIALLERGIC AGENTS ALMIRALL PRODESFARMA SA (ES) 2004-02-11 EP disclosed
US-6683096-B2 Indolylpiperidine derivatives as antihistaminic and antiallergic agents ALMIRALL PRODESFARMA, S.A. (ES) 2004-01-27 US disclosed
US-20020147344-A1 Indolylpiperidine derivatives as antihistaminic and antiallergic agents ALMIRALL PRODESFARMA, S.A. (ES) 2002-10-10 US disclosed
CN-1368969-A Indolylpiperidine derivatives as antihistaminic and antiallergic agents ALMIRALL PRODESFARMA SA (ES) 2002-09-11 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020147344-A1 Indolylpiperidine derivatives as antihistaminic and antiallergic agents HRH2, HRH1, HRH4 HDAC1 483/4885HDAC3 361/4885HDAC4 890/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.